Pinkham, Amy E. http://orcid.org/0000-0003-2803-4520
Ackerman, Robert A.
Depp, Colin A.
Harvey, Philip D.
Moore, Raeanne C.
Article History
Received: 20 September 2020
Accepted: 22 December 2020
First Online: 3 February 2021
Competing interests
: R.C.M. is a co-founder of KeyWise AI, Inc., and a consultant for NeuroUX. P.D.H. has received consulting fees or travel reimbursements from Acadia Pharma, Alkermes, Bio Excel, Boehringer Ingelheim, Minerva Pharma, Otsuka Pharma, Regeneron Pharma, Roche Pharma, and Sunovion Pharma during the past year. He receives royalties from the Brief Assessment of Cognition in Schizophrenia. He is the chief scientific officer of i-Function, Inc. He had a research grant from Takeda and from the Stanley Medical Research Foundation. None of these companies provided any information to the authors that is not in the public domain. No other authors have conflicts of interest to report.